Royalty Pharma plc (RPRX) Dividend Yield, History & Forecast

Royalty Pharma plc (RPRX) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the NASDAQ. It pays a current dividend yield of 1.57% ($0.93 per share annually (TTM)), with 4 years of consecutive dividend increases. The most recent ex-dividend date was August 14, 2026, with payment scheduled for September 10, 2026. The trailing twelve-month payout ratio is 48.9%; the market capitalization is approximately $25.98B. Review RPRX dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

Frequently Asked Questions about Royalty Pharma plc (RPRX)

What is Royalty Pharma plc's dividend yield?
Royalty Pharma plc (RPRX) pays a current trailing twelve-month dividend yield of 1.57%, which works out to $0.93 per share annually based on the most recent payout schedule.
When does Royalty Pharma plc pay its next dividend?
The most recent ex-dividend date was August 14, 2026. The next scheduled dividend payment date is September 10, 2026.
How many years has Royalty Pharma plc increased its dividend?
Royalty Pharma plc (RPRX) has increased its dividend for 4 consecutive years.
Is Royalty Pharma plc a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. Royalty Pharma plc (RPRX) currently has 4 years of consecutive increases.
What sector is Royalty Pharma plc in?
Royalty Pharma plc (RPRX) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.
What is Royalty Pharma plc's dividend payout ratio?
Royalty Pharma plc (RPRX)'s trailing twelve-month dividend payout ratio is 48.9%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.